Participants underwent 5 Virtual Touch UDFF and Auto-pSWE measurements using the DAX, and 10 vibration-controlled transient elastography (VCTE) and CAP (CAP) measurements using the appropriate M- or XL-probe on the Fibroscan
glp-1 agonist incretin effect GLP-1 Drugs: A Complete History of Incretin-Based Therapy November 2, 2025 Updated March 8, 2026 70 min read Learn the complete history of GLP-1 drugs from the incretin effect to 2026 breakthroughs
Lab ordering supports safety checks and helps identify metabolic risks
Retrieved from Igarashi, A., Hansen, B
This webinar will equip RDNs with the clinical insight, trend intelligence, and communication strategies needed to counsel patients effectively, engage with food industry partners, and lead the GLP-1 conversation with authority